The U.S. Food and Drug Administration (FDA) recently issued a draft guidance, “Master Protocols for Drug and Biological Product Development”, that echoes and builds on principles that the Agency ...
The FDA released a revised draft guidance on June 22, 2026 offering updated recommendations on the design, analysis, and regulatory submission of clinical trials conducted under master protocols. 1 ...
An official from the US Food and Drug Administration (FDA) recommended that developers of COVID-19 drugs consider using master protocols to assess the benefits and the risks of potential COVID-19 ...
A new guidance from the US Food and Drug Administration (FDA) addresses how master protocols can be used in developing drugs to treat or prevent COVID-19. “To meet the urgent demand for effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results